Arcutis Biotherapeutics
Price & Volume
Stats
See more52W Range | $6.99-$17.70 |
Market Cap | $2B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $196.5M |
Revenue Growth (YoY) | 427.6% |
Gross Profit (12 Mos) | $177.4M |
Diluted EPS | -$1.16 |
News
See moreYahoo Finance • 19 days ago
Arcutis to Highlight Data from Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting
Yahoo Finance • 20 days ago
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 25 days ago
Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting
Yahoo Finance • last month
Arcutis to Present at the TD Cowen 45th Annual Health Care Conference
About
CEO | Mr. Todd Franklin Watanabe M.A. |
Address | 3027 Townsgate Road, Westlake Village, CA, United States, 91361 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 342 |
